Author

Ananya A. Basu

Northwestern UniversityORCID 0000-0002-1427-5326Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Anil VasudevaniD· 1 shared Brayley S. GattisiD· 1 shared Chenlu ZhangiD· 1 shared Julia OktawieciD· 1 shared Justin M. ReitsmaiD· 1 shared Max Mu WangiD· 1 shared Mihai Ioan TruicaiD· 1 shared Milad Rouhimoghadam· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Anil VasudevanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintMar 7, 2025

Heterobifunctional proteomimetic polymers for targeted protein degradation

Max Mu Wang, Mihai Ioan Truica, Brayley S. Gattis…·Nathan C. Gianneschi

This paper introduces HYDRAC, a polymer-based platform for targeted protein degradation, demonstrating its effectiveness in degrading MYC and KRAS in vitro and in vivo.

DOI 10.1101/2025.03.07.641543

experimental assaydrug response / drug discovery

𝕏 PostBluesky

BiochemistryJournal of the American Chemical SocietyPeer-reviewedFeb 6, 2025

Harnessing the FBXW7 somatic mutant R465C for targeted protein degradation

Ananya A. Basu, Chenlu Zhang, Milad Rouhimoghadam…·Xiaoyu Zhang

This study shows that the FBXW7 R465C somatic mutant can be used for targeted protein degradation via heterobifunctional compounds.

4 citations

experimental assay

𝕏 PostBluesky